- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07247916
Développement et Pilotage d'une Stratégie de Mise en Œuvre pour une Intervention Brève de Conseil sur la Sécurité des Moyens Létaux Basée sur l'Entretien Motivationnel en Milieu de Soins Primaires (CDA-2)
Développement et pilotage d'une stratégie de mise en œuvre pour une intervention brève de conseil en matière de sécurité des moyens létaux basée sur l'entretien motivationnel en milieu de soins primaires
Suicide prevention remains a significant priority and nearly three-quarters of Veteran suicides result from firearm injury. Since access to lethal means of self-harm increases the risk of injury, the VA/DoD Clinical Practice Guidelines recommend that Veterans with elevated suicide risk receive lethal means safety (LMS) counseling to reduce access to lethal means, including firearms. However, no LMS counseling interventions have been tested within VA. Thus, the aim of this study is to conduct a pilot randomized controlled trial to evaluate the feasibility and acceptability of a tailored LMS counseling intervention compared to an active control condition.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This is a pilot randomized controlled trial of up to 50 Veterans to assess the feasibility and acceptability of a LMS intervention and testing procedures.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Steve Martino, PhD
- Numéro de téléphone: 2468 (203) 932-5711
- E-mail: Steve.Martino@va.gov
Sauvegarde des contacts de l'étude
- Nom: Frances Aunon, PhD MS
- Numéro de téléphone: 7894 (203) 932-5711
- E-mail: Frances.Aunon@va.gov
Lieux d'étude
-
-
Connecticut
-
West Haven, Connecticut, États-Unis, 06516-2770
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT
-
Contact:
- Steve Martino, PhD
- Numéro de téléphone: 2468 (203) 932-5711
- E-mail: Steve.Martino@va.gov
-
Contact:
- Kimberly L Selander, MA
- Numéro de téléphone: (203) 932-5711
- E-mail: Kimberly.Selander@va.gov
-
Chercheur principal:
- Frances Aunon, PhD MS
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
For Veterans:
- Has access to a firearm
- Referred to Primary Care Mental Health Integration (PCMHI) care
For clinicians (delivering intervention):
- Deliver care in Primary Care Mental Health Integration (PCMHI)
- Trained in RAMP and study procedures
Exclusion Criteria:
For Veterans:
- Unable to consent due to cognitive impairment, severity of illness (including psychiatric symptoms), intoxication with drugs and/or alcohol
- Unreliable telephone access
- Inability to read English or communicate in spoken and written English
For clinicians (delivering intervention):
- Did not participate in training
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Active control
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting. |
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting. |
|
Expérimental: RAMP
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage |
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Screening
Délai: through study completion, approximately 2 years
|
Investigators will assess the number of new Primary Care Mental Health Integration (PCMHI) patients seen in PCMHI and the number who were approached about potential study participation per month |
through study completion, approximately 2 years
|
|
Recruitment
Délai: through study completion, approximately 2 years
|
Investigators will track the number of eligible Veterans who enrolled in the study per month |
through study completion, approximately 2 years
|
|
Retention
Délai: approximately 30 days
|
Investigators will calculate the number of Veterans who received RAMP who were willing to complete immediate and one-month follow up assessments. |
approximately 30 days
|
|
Assessment of behavioral outcomes
Délai: approximately 30 days
|
Investigators will assess the percentage of participants who completed behavioral outcome measures within the time allotted at each timepoint |
approximately 30 days
|
|
Veteran acceptability - Theoretical Framework of Acceptability
Délai: At immediate follow up, within approximately 2 weeks of intervention
|
Investigators will assess Veteran acceptability using the eight Likert-style items from the Theoretical Framework of Acceptability questionnaire, which assess seven component constructs of acceptability including Veteran's experience of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability. |
At immediate follow up, within approximately 2 weeks of intervention
|
|
Veteran acceptability - Experience and Satisfaction with intervention
Délai: At immediate follow up, within approximately 2 weeks of intervention
|
Investigators will conduct qualitative evaluation of the participant's experience and satisfaction receiving the intervention. |
At immediate follow up, within approximately 2 weeks of intervention
|
|
Clinician acceptability - Theoretical Framework of Acceptability
Délai: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Investigators will invite clinicians to respond to the eight-item Theoretical Framework of Acceptability questionnaire eliciting clinician acceptability of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability. |
at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
|
Clinician acceptability - Negative impact
Délai: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Investigators will assess to what extent Primary Care Mental Health Integration (PCMHI) clinicians agree that study recruitment negatively impacted clinical care, using Likert-type items where '1' indicates "strongly disagree" and '5' indicates "strongly agree." For those responding >3 ("don't know"), an open-ended question will elicit detailed information (e.g., interfered with delivery of clinical care, led to Veteran frustration). |
at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Frances Aunon, PhD MS, VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- HSR4-001-24W
- 1IK2RD000503-01A2 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .